first commit
This commit is contained in:
commit
0d90363116
6510 changed files with 679146 additions and 0 deletions
58
data/nsa-medint-intercept-15-0521/metadata.json
Normal file
58
data/nsa-medint-intercept-15-0521/metadata.json
Normal file
|
|
@ -0,0 +1,58 @@
|
|||
{
|
||||
"title": "Medical Pattern of Life - Targeting High Value Individual #1 - (SIGINT Enabling HUMINT / Targeting)",
|
||||
"type": "REPORTED",
|
||||
"description": "This presentation dates from June 2010 and outlines a highly specialized intelligence strategy: using a target's medical needs as a \"geospatial beacon\" to bypass traditional security measures. In this context, High Value Individual #1 (HVI #1) refers to Osama bin Laden (UBL), and the document details a plan to track him via his suspected chronic kidney disease and related medical supplies.",
|
||||
"long_description": "The provided document, titled \"Medical Pattern of Life: Targeting High Value Individual #1,\" is a high-level briefing from a 2010 SIGINT Development Conference detailing a specialized methodology for locating high-value targets. The core of the presentation focuses on \"Medical Intelligence\" and the \"Medical Pattern of Life,\" which is defined as the identification of predictable, recurring behaviors tied to a target's specific medical treatment regimen. This approach is presented as a superior alternative to conventional intelligence because medical needs create a physical supply chain that persists even when a target successfully avoids using electronic devices or telecommunications.\n\nThe primary case study involves High Value Individual #1, identified through context as Osama bin Laden (\"UBL\"). The intelligence community utilized a combination of signals intelligence and human intelligence to construct a detailed medical profile of the target, who was believed to be suffering from middle-stage renal disease, recurrent kidney stones, and chronic urinary tract infections. By analyzing this specific \"medical treatment signature,\" the NSA and its partners identified the exact pharmaceuticals and equipment required to keep the target alive, such as peritoneal dialysis solutions and E-Poetin injections. Because these supplies must eventually reach the target, they serve as a unique vulnerability that can be exploited to \"leap over\" the non-electronic moat surrounding the individual.\n\nTo execute this targeting, the project proposed a \"pharmaceutical honey-pot\" operation involving sophisticated technical solutions. This included the use of tiny, low-power RFID tags, such as PAITS from Sandia National Laboratories, which were designed to be embedded into medical packaging. Furthermore, the plan detailed the use of gas taggants that would release a detectable signal the moment a pharmaceutical seal was broken. Once these tagged supplies reached their destination and were opened for use, the system would trigger long-range geolocation and independent confirmation of the target's position, ultimately enabling a terminal military or intelligence operation.",
|
||||
"tags": [
|
||||
"Medical Pattern of Life",
|
||||
"PoL",
|
||||
"High Value Individuals",
|
||||
"humint",
|
||||
"Medical Intelligence",
|
||||
"MEDINT",
|
||||
"supply chain attacks",
|
||||
"SSO",
|
||||
"drugs",
|
||||
"pharmaceuticals",
|
||||
"diseases",
|
||||
"illness",
|
||||
"geolocation"
|
||||
],
|
||||
"document": {
|
||||
"creator": "NSA",
|
||||
"date_created": "2010-06",
|
||||
"classification": [
|
||||
"TOP SECRET",
|
||||
"SI",
|
||||
"COMINT"
|
||||
],
|
||||
"dissemination": [
|
||||
"REL"
|
||||
],
|
||||
"banner": "TOP SECRET//COMINT//REL",
|
||||
"genre": "slides",
|
||||
"programs": [],
|
||||
"countries": [],
|
||||
"people": [
|
||||
"bin Laden, Osama"
|
||||
]
|
||||
},
|
||||
"publication": [
|
||||
{
|
||||
"publisher": "The Intercept",
|
||||
"date_published": "2015-05-21",
|
||||
"title": "The NSA Plan to Find Bin Laden by Hiding Tracking Devices in Medical Supplies",
|
||||
"link": "https://theintercept.com/2015/05/21/nsa-plan-find-osama-bin-laden-infiltrating-medical-supply-chain/",
|
||||
"reporters": [
|
||||
"Currier, Cora"
|
||||
],
|
||||
"contributors": [
|
||||
"Fishman, Andrew",
|
||||
"Williams, Margot"
|
||||
],
|
||||
"doc_url": "https://s3.documentcloud.org/documents/2084666/medical-pattern-of-life-targeting-high-value.pdf"
|
||||
}
|
||||
],
|
||||
"pdf_sha256": "03473c0d2f3de02e3654feebc60308c4816f8ac3529954450a80b202cd9d229f",
|
||||
"pages": 10
|
||||
}
|
||||
|
|
@ -0,0 +1,172 @@
|
|||
NATIONAL SECURITY AGENCY
|
||||
UNITED STATES OF AMERICA
|
||||
|
||||
CENTRAL SECURITY SERVICE
|
||||
UNITED STATES OF AMERICA
|
||||
|
||||
SIGNALS INTELLIGENCE
|
||||
SI
|
||||
DIRECTORATE
|
||||
|
||||
UNCLASSIFIED//FOUO
|
||||
|
||||
# Medical Pattern of Life
|
||||
## Targeting High Value Individual #1
|
||||
## (SIGINT Enabling HUMINT / Targeting)
|
||||
|
||||
SIGINT Development Conference
|
||||
June 2010
|
||||
|
||||
Dr. [REDACTED], SSG13, Clinical Psychologist to Operations
|
||||
[REDACTED], SSG13, Senior Technical Development Program
|
||||
|
||||
UNCLASSIFIED//FOUO
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (U) Outline
|
||||
|
||||
* (U) Project Description
|
||||
* (U) Definition of Medical Pattern of Life(POL)
|
||||
* (S//SI//REL) Advantages of Medical Intel over Conventional Intel in Prosecuting HVI's.
|
||||
* (TS//SI//REL) UBL Medical SIGINT Amplified by HUMINT
|
||||
* (TS//REL) Medical Profile for HVI#1
|
||||
* New Intelligence + Extrapolated
|
||||
* (FOUO) Planned Modus Operandi
|
||||
* (FOUO) Technical Solution to Enable Operation
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (C//REL) Medical Intelligence
|
||||
|
||||
* (C//REL) What is Medical Intelligence?
|
||||
* (S//SI//REL) Methodology used for Extracting Medical Pattern of Life (PoL) from Medical Intelligence.
|
||||
* (TS//SI//REL) Medical PoL → Identification of all recurring, and therefore predictable, patterns of behavior that constitute the specific treatment regimen for a target's medical illness
|
||||
* Medications, Medical Tests, Medical Surgical Treatments, Hospital and Doctor Visits
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (S//REL) High Value Individual Targeting
|
||||
|
||||
* (TS//SI//REL) Advantages of Medical Intel:
|
||||
* Credible Medical Intel Never Goes Stale
|
||||
* Tagging and tracking medications/supplies to a specific target enables us to leap over the non-electronic moat with which HVI's surround themselves, enabling their geolocation.
|
||||
* Enables Geolocation in Cities or Countryside.
|
||||
* (S//REL) Case Examples of the use of Medical PoL for GeoLocation Targets.
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (FOUO) Medical Profile
|
||||
|
||||
* (TS//SI//REL) Description of UBL Medical PoL
|
||||
* (TS//SI//REL) SIGINT Reporting on UBL
|
||||
* Doctor in Theater, 2000
|
||||
* (TS//SI//REL) CIA Reports
|
||||
* "Middle Stage Renal Disease”
|
||||
* Recurrent Urinary Tract Infections and Kidney Stones
|
||||
* Intestinal Problems
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (U) Project Planning
|
||||
|
||||
* (S//REL) Acquire Support from Stakeholders
|
||||
* British (GCHQ, SIS)
|
||||
* US (RX, LPS, Sandia, ORNL, NSA CT, CIA CT)
|
||||
* (FOUO) Technical Solution Trade Study
|
||||
* (S//REL) Determine Medical Treatment Signature
|
||||
* (S//REL) Determine Likely Meds/Equipment
|
||||
* (TS//SI//REL) Focus Tag Effort: Supply Chain to HVI
|
||||
* Suppliers, ICRC Hospitals, Agents in Field
|
||||
* 2006 Reporting- Kandahar Supply Chain
|
||||
* HUMINT
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (FOUO) Technical Considerations
|
||||
|
||||
* (TS//REL) Device
|
||||
* Tiny, Embeddable Form Factor
|
||||
* Very Low Power
|
||||
* Non-Attributable Electronics
|
||||
* (TS//REL) Communications
|
||||
* Long Stand-Off Range, Covert
|
||||
* (TS//REL) System
|
||||
* Accuracy Despite Harsh Signal Environments
|
||||
* Existing Infrastructure
|
||||
* (TS//SI//REL) Alternatives
|
||||
* RFID System: Sandia National Lab PAITS, LPS, RX
|
||||
* Enabling Taggant: RX, ORNL
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (FOUO) Mechanics
|
||||
|
||||
* (TS//SI//REL) PAITS Long Range Tags
|
||||
* Apply to Pharmaceuticals / Delivery System
|
||||
* Where Repackaging not an Option
|
||||
* Peritoneal Dialysis Solution- IV Bags
|
||||
* E-Poetin Injection Bottles
|
||||
* Native Tag Issues (RF Interference, Cover)
|
||||
* Very High Probability Destination- HVI#1
|
||||
* Intelligence / HUMINT Enabling
|
||||
* Pharmaceutical Honey-Pot
|
||||
* (TS//SI//REL) Gas Taggant Indicator
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
## (FOUO) Operation
|
||||
|
||||
* (TS//REL) Known Conduit: Pharma to Target
|
||||
* (TS//SI//REL) Process
|
||||
* Seal Broken for Pharmaceutical Use
|
||||
* Gas Release/Detection
|
||||
* Initiate RFID Tracking System
|
||||
* (TS//SI//REL) GeoLocate Tags at Long Range
|
||||
* (TS//REL) Independently Confirm Target Location
|
||||
* (TS//REL) Initiate Operation on Acquired Target
|
||||
|
||||
TOP SECRET//COMINT//REL
|
||||
|
||||
---
|
||||
|
||||
UNCLASSIFIED//FOUO
|
||||
|
||||
## (U) Questions?
|
||||
|
||||
(FOUO) Contact Information:
|
||||
|
||||
* Dr. [REDACTED], SSG13 @nsa [REDACTED]
|
||||
* [REDACTED], STDP / SSG13 @nsa [REDACTED]
|
||||
|
||||
UNCLASSIFIED//FOUO
|
||||
Loading…
Add table
Add a link
Reference in a new issue